Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Leadership
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Offices
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Far East
        • Far East Region Leadership
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
      • Special Agent Job Announcements
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Search
  • Full Menu

Main Menu

  • Who We Are
  • What We Do
  • Careers
  • Resources
  • Submit A Tip
  • Get Updates
  • Scam Alert
  • English
  • ES

PUBLIC SAFETY ALERT

DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine - DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine

Drug Enforcement Administration

Brian D. Boyle Special Agent in Charge
New England
@DEANewEngland
September 12, 2019
Contact: Kristen Carosa
Phone Number: (617) 557-2100
For Immediate Release

Eight defendants arrested for distributing millions of opioid pills from India

BROOKLYN, N.Y. - Earlier today, a complaint was unsealed in federal court in Brooklyn charging eight defendants, Ezhil Sezhian Kamaldoss, Harpreet Singh, Parthiban Narayanasamy, Baljeet Singh, Deepak Manchanda, Gulab Gulab, Mukul Chugh and Vikas M. Verma with conspiring to possess with intent to distribute a controlled substance containing Tramadol, a synthetic opioid. The defendants were arrested this morning, and their initial appearances are scheduled for this afternoon before United States Magistrate Judge Lois Bloom.

 

DEA New England Division Special Agent in Charge Brian D. Boyle; Richard P. Donoghue, United States attorney for the Eastern District of New York; Mark McCormack, special agent-in-charge, Food and Drug Administration, Office of Criminal Investigations, Metro Washington Field Office (FDA-OCI); Todd A. Wickerham, special agent-in-charge, Federal Bureau of Investigation, Cincinnati Field Office (FBI); Philip R. Bartlett, inspector-in-charge, United States Postal Inspection Service, New York Division (USPIS); John Eisert, special agent-in-charge, Homeland Security Investigations (HSI), Baltimore Field Office; Peter C. Fitzhugh, special agent-in-charge, HSI, New York Field Office; Troy Miller, director of Field Operations, U.S. Customs and Border Protection, New York Field Office (CBP) announced the charges.

 

Since approximately January 2018, law enforcement agents with FDA-OCI, USPIS, HSI, CBP, DEA, FBI and other agencies have been investigating the large-scale importation of misbranded controlled substances, including Tramadol, into the United States from India. As part of the defendants’ scheme, distributors in India shipped misbranded Tramadol and other drugs to individuals and entities in the United States through the U.S. mail and other commercial couriers. The defendants primarily operated out of a warehouse in Queens where they repackaged the pills and mailed them to customers throughout the United States. The defendants maintained daily ledgers detailing the names, addresses, pill size and pill amounts ordered by customers. During the course of the investigation, the defendants distributed millions of Tramadol pills.  

 

Ezhil Sezhian Kamaldoss is also charged with money laundering.

 

“DEA is addressing the threat of opioids, both internationally and domestically. We prioritize our resources by identifying and targeting the world’s biggest and most powerful drug traffickers and their organizations,” said Boyle. “The diversion of prescription pain killers contribute to the widespread abuse of opioids which is a gateway to addiction and is devastating our communities. DEA will continue to collaborate with our federal, state and local law enforcement partners to hold accountable those who are fueling this epidemic.”

 

“As alleged, the defendants participated in a black market for prescription medications by distributing millions of opioid pills in tens of thousands of transactions in one year alone,” said Donoghue. “This Office and our law enforcement partners will continue to vigorously investigate and prosecute those who profit from the suffering wrought by opioid distribution in the United States. Mr. Donoghue expressed his appreciation to the United States Attorneys’ Offices for the District of Maryland, the District of Massachusetts and the Southern District of Ohio for their assistance in the case."

 

“The illegal manufacture and distribution of opioids can result in overdoses and deaths, further fueling the national crisis,” said FDA Special Agent-in-Charge McCormack. “The FDA is committed to disrupting and dismantling illegal prescription drug distribution networks, including those that import unapproved drugs from overseas, and distribute those drugs with reckless disregard of the risk to public health.”

 

“The importation of mislabeled drugs is both dangerous and illegal,” stated FBI Special Agent-in-Charge Wickerham. “It contributes to the ongoing opioid crisis in our nation and causes harm to our communities.”

 

“Postal Inspectors are always at the forefront in protecting communities from the scourge of illegal drugs, no matter how they enter this country, and today’s arrests are a shining example of our commitment to keep the public safe,” stated USPIS Inspector-in-Charge Bartlett.

 

“These individuals chose greed and profit at the cost of human lives. HSI is committed to investigating and ending these kinds of drug trafficking schemes to keep opioids off our streets,” said HSI Special Agent-in-Charge Eisert.

 

“American communities continue to be plagued by synthetic opioids, often at the hands of dealers like those accused in this investigation,” said HSI Special Agent-in-Charge Fitzhugh. “HSI is committed to aggressively targeting every level of the opioid supply chain, from the overseas vendors to the street-level dealers, in an effort to end this crisis.”

 

“This case serves as a great example of collaborative law enforcement efforts to combat international opioid trafficking conspirators. U.S. Customs and Border Protection thanks our partners at FBI, FDA, USPIS, HSI and DEA for their continued cooperation,” said CBP Director of Field Operations Miller.

 

The charges in the complaint are allegations, and the defendants are presumed innocent unless and until proven guilty.  If convicted, Ezhil Sezhian Kamaldoss faces up to 25 year's imprisonment.  The remaining defendants each face up to five year's imprisonment.

 

The Defendants:

 

MUKUL CHUGH Age: 24 Long Island City, New York

 

GULAB GULAB Age: 45 Richmond Hill, New York

 

EZHIL SEZHIAN KAMALDOSS (also known as Kamaldoss Sezhian,” “Kamal Doss” and “Ezhil Cezhian”) Age: 46 Richmond Hill, New York

 

DEEPAK MANCHANDA Age: 43 Deer Park, New York

 

PARTHIBAN NARAYANASAMY (also known as “Pat”) Age: 58 Jamaica, New York

 

BALJEET SINGH (also known as “Sunny”) Age: 29 Richmond Hill, New York

 

HARPREET SINGH (also known as “Vicky Singh”) Age: 28 Plainview, New York

 

VIKAS M. VERMA Age: 45 Dix Hills, New York

 

 

 

 

                                                                        ###

Synthetic Opioids
  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
Home

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster